GT Biopharma (OTCMKTS:GTBP) Stock Price Up 23.1%

Shares of GT Biopharma Inc (OTCMKTS:GTBP) rose 23.1% on Monday . The stock traded as high as $0.16 and last traded at $0.16, approximately 313,738 shares changed hands during trading. An increase of 142% from the average daily volume of 129,852 shares. The stock had previously closed at $0.13.

The firm has a 50 day moving average price of $0.18 and a two-hundred day moving average price of $0.14.

GT Biopharma (OTCMKTS:GTBP) last posted its quarterly earnings results on Friday, May 15th. The company reported ($0.02) earnings per share for the quarter.

About GT Biopharma (OTCMKTS:GTBP)

GT Biopharma, Inc, a clinical stage biopharmaceutical company, focuses on the development and commercialization of novel immuno-oncology products based off its proprietary technology platforms. The company develops immuno-oncology product candidates, including OXS-1550, a bispecific scFv recombinant fusion protein-drug conjugate that targets cancer cells expressing the CD19 receptor or CD22 receptor, or both receptors; OXS-3550, a single-chain, tri-specific scFv recombinant fusion protein conjugate targeting CD33+ malignancies; OXS-C3550, a next-generation version of OXS-3550 containing a modified CD16 component; and OXS-1615, a single-chain fusion protein that targets epithelial tumors and CD133 positive solid tumors.

Read More: What is a recession?

Receive News & Ratings for GT Biopharma Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for GT Biopharma and related companies with MarketBeat.com's FREE daily email newsletter.



Comments


share news on Facebook
tweet this investment news
share on linkedin
share on StockTwits
share on reddit